Literature DB >> 30006470

Fetal surgery for spina bifida aperta.

Luc Joyeux1,2, Enrico Danzer3,4, Alan W Flake3,4, Jan Deprest1,2,5,6.   

Abstract

Spina bifida aperta (SBA) is one of the most common congenital malformations. It can cause severe lifelong physical and neurodevelopmental disabilities. Experimental and clinical studies have shown that the neurological deficits associated with SBA are not simply caused by incomplete neurulation at the level of the lesion. Additional damage is caused by prolonged exposure of the spinal cord and nerves to the intrauterine environment and a suction gradient due to cerebrospinal fluid leakage, leading to progressive downward displacement of the hindbrain. This natural history can be reversed by prenatal repair. A randomised controlled trial demonstrated that mid-gestational maternal-fetal surgery for SBA decreases the need for ventriculoperitoneal shunting and hindbrain herniation at 12 months and improves neurological motor function at 30 months of age. This came at the price of maternal and fetal risks, the most relevant ones being increased prematurity and a persistent uterine corporeal scar. Recently minimally invasive fetal approaches have been introduced clinically yet they lack extensive experimental or clinical trials. We aim to provide clinicians with the essential information necessary to counsel SBA parents as the basis for considering referral of selected patients to expert fetal surgery centres. We review the reported clinical outcomes and discuss recent developments of potentially less invasive fetal SBA approaches. © Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  fetal surgery; fetoscopy; myelomeningocele; open fetal surgery; spina bifida aperta

Mesh:

Year:  2018        PMID: 30006470     DOI: 10.1136/archdischild-2018-315143

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  5 in total

1.  Heritable spina bifida in sheep: A potential model for fetal repair of myelomeningocele.

Authors:  John W Steele; Sharon Bayliss; John Bayliss; Ying Linda Lin; Bogdan J Wlodarczyk; Robert M Cabrera; Yohannes G Asfaw; Thomas J Cummings; Richard H Finnell; Timothy M George
Journal:  J Pediatr Surg       Date:  2019-06-29       Impact factor: 2.545

2.  [Preliminary analysis of the clinical characteristics of 1 012 patients with secondary lower limb deformity of spina bifida from QIN Sihe Orthopedic Surgery Case Data between October 12, 1986 and December 31, 2020].

Authors:  Sihe Qin; Baofeng Guo; Yilan Wang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-11-15

Review 3.  Spinal Cord Injury in Myelomeningocele: Prospects for Therapy.

Authors:  Karolina Janik; Meredith A Manire; George M Smith; Barbara Krynska
Journal:  Front Cell Neurosci       Date:  2020-06-30       Impact factor: 5.505

4.  Validation of the Fetal Lamb Model of Spina Bifida.

Authors:  Luc Joyeux; Alexander C Engels; Johannes Van Der Merwe; Michael Aertsen; Premal A Patel; Marjolijn Deprez; Ahmad Khatoun; Savitree Pranpanus; Marina Gabriela Monteiro Carvalho Mori da Cunha; Stephanie De Vleeschauwer; Johanna Parra; Katerina Apelt; Myles Mc Laughlin; Frank Van Calenbergh; Enrico Radaelli; Jan Deprest
Journal:  Sci Rep       Date:  2019-06-27       Impact factor: 4.379

5.  Transamniotic mesenchymal stem cell therapy for neural tube defects preserves neural function through lesion-specific engraftment and regeneration.

Authors:  Xiaowei Wei; Wei Ma; Hui Gu; Dan Liu; Wenting Luo; Yuzuo Bai; Weilin Wang; Vincent Chi Hang Lui; Peixin Yang; Zhengwei Yuan
Journal:  Cell Death Dis       Date:  2020-07-13       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.